S-1: BIO-key Registers 6.18M Shares for Resale, Raises Capital

BIO-key International, Inc. filed an S-1 registration statement for the resale of up to 6.18 million common shares by a selling stockholder, while also detailing recent warrant exercises that generated over $9 million for the company.

Summary

• BIO-key International, Inc. filed a Form S-1 registration statement for the resale of up to 6,183,336 shares of its common stock by Armistice Capital Master Fund Ltd., a selling stockholder.
• The shares being registered for resale are issuable upon the exercise of warrants previously issued to the selling stockholder.
• The company will not receive any proceeds from the sale of shares by the selling stockholder in this offering.
• However, the company expects to receive aggregate gross proceeds of $6,307,002.72 from the full exercise of the 6,183,336 warrants at an exercise price of $1.02 per share.
• These proceeds are intended for working capital and general corporate purposes, including the repayment of a portion of the company's outstanding secured note.
• As of November 13, 2025, BIO-key had 10,836,618 shares of common stock outstanding; after the full exercise of these warrants, the total outstanding shares would be 17,019,954.
• The company's common stock is listed on the Nasdaq Capital Market under the symbol BKYI, with a closing price of $1.03 per share on November 18, 2025.
• The auditor's report dated April 23, 2025, for the years ended December 31, 2023 and 2024, includes an explanatory paragraph regarding the company's ability to continue as a going concern.

Sentiment

Score: 4

Explanation: The filing presents a mixed picture. While the company has successfully raised capital through warrant exercises and outlines clear growth strategies in an expanding market, the explicit 'going concern' warning from the auditor and the 'history of losses and limited revenue' are significant negative indicators. The potential for substantial dilution from the registered resale also weighs on sentiment, despite the company receiving proceeds from the underlying warrant exercises.

Positives

• The company has successfully raised capital through multiple warrant exercise agreements, totaling approximately $9.35 million in gross proceeds (excluding the current $6.3M potential proceeds) over the past year, which will be used for working capital and debt repayment.
• BIO-key is actively pursuing growth strategies, including expanding its role in the Identity Access Management (IAM) market, offering a broader suite of authentication options, and targeting government, higher education, and highly-regulated industries.
• The company has grown its channel alliance program to over eighty-five participants, which is generating incremental revenues.
• Strategic acquisitions are a component of the growth strategy, with the company regularly evaluating businesses that could provide entry into new market verticals or be synergistic and accretive to earnings.

Negatives

• The auditor's report for the fiscal years ended December 31, 2023 and 2024, includes an explanatory paragraph regarding the company's ability to continue as a going concern, indicating significant financial uncertainty.
• The company has a history of losses and limited revenue, which is a stated risk factor.
• The company will not receive any proceeds from the resale of the 6,183,336 shares by the selling stockholder, limiting direct capital infusion from this specific registration.
• Sales of a substantial number of shares (approximately 36% of outstanding common stock after warrant exercise) in the public market could lower the stock price and impair the company's ability to raise future funds.
• Investors will suffer dilution with any additional issuance of common stock, and the company may experience dilution in its earnings per share.
• The company faces risks related to its ability to raise additional capital and maintain an active trading market for its shares.

Risks

• Sales of a substantial number of common stock shares, including the 6,183,336 shares offered under this prospectus, could lower the stock price and impair the company's ability to raise funds in new stock offerings.
• Future issuances of common stock will cause dilution to investors and may dilute earnings per share.
• An active trading market for the company's shares may not be sustained, impairing investors' ability to sell shares and the company's ability to raise capital or acquire assets.
• The company has a history of losses and limited revenue.
• There is uncertainty regarding the company's ability to raise additional capital.
• The company's ability to continue as a going concern is a significant risk, as noted by its independent registered public accounting firm.
• Risks exist regarding the company's ability to protect its intellectual property.
• Changes in business conditions, sales strategy, product development plans, and the marketplace could adversely affect operations.
• The continued services of the executive management team are crucial, and their loss could be detrimental.
• The company is exposed to risks of security breaches.
• Significant competition exists in the biometric technology and identity access management industries.
• Market acceptance of biometric products generally and the company's products under development is uncertain.
• The company's ability to convert sales opportunities to customer contracts is a risk.
• Challenges exist in expanding into Asia, Africa, and other foreign markets.
• There is a risk in migrating Swivel Secure customers to BIO-key and PortalGuard offerings.
• The company's ability to execute definitive agreements with Fiber Food Systems and/or its customers and integrate solutions into Fiber Food Systems offerings is uncertain.
• Fluctuations in foreign currency exchange rates could impact financial results.
• The duration and extent of hostilities in Ukraine and their impact on European customers pose a risk.
• Impact of tariffs and other trade barriers (e.g., from China, Hong Kong, South Korea) may increase import costs.
• Delays in the development of products could affect market competitiveness.
• Commercial, reputational, and regulatory risks may arise from the restatement of financial statements, including non-compliance with SEC and Nasdaq periodic reporting requirements.
• The company faces a temporary loss of the use of a Registration Statement on Form S-3 to register securities in the future.
• Disruption to the business may occur if the company is unable to maintain effective internal controls over financial reporting.

Future Outlook

The company plans to expand its role in the Identity Access Management (IAM) market by offering a more comprehensive suite of authentication options, complementing its biometric solutions. It expects to grow its business within government services, higher education, financial services, and healthcare, driven by heightened security and privacy requirements. Strategic initiatives include increased marketing, dedicated pursuit of large-scale identification projects globally, and growing its channel alliance program. The company also intends to pursue strategic acquisitions of select businesses and assets in the IAM space that are synergistic and accretive to earnings.

Management Comments

• We plan to have a more significant role in the IAM market which continues to expand.
• We plan to continue to offer customers a suite of authentication options that complement our biometric solutions.
• We expect to grow our business within government services, higher education, and highly-regulated industries.
• We believe that continued heightened security and privacy requirements in these industries, and as colleges and universities continue operating in remote environments, we will generate increased demand for security solutions, including biometrics.
• We expect that the compatible, yet superior portable biometric user experience offered by our technology for Windows 10 users will accelerate the demand for our computer network log-on solutions and fingerprint readers.
• We are active in the industry and regularly evaluate businesses that we believe will either provide an entry into new market verticals or be synergistic with our existing operations and in either case, be accretive to earnings.

Industry Context

BIO-key operates in the expanding Identity Access Management (IAM) market, which is experiencing increased demand due to heightened security and privacy requirements across various sectors, particularly government, higher education, financial services, and healthcare. The company's focus on biometric solutions and multi-factor authentication (MFA) aligns with the industry trend towards stronger, more flexible authentication methods. Its SaaS business model and channel partner strategy are standard approaches in the software industry for scaling customer reach and recurring revenue. The pursuit of strategic acquisitions indicates a consolidation trend within the IAM space as companies seek to broaden their offerings and market share.

Comparison to Industry Standards

• The filing does not provide specific comparisons to comparable companies, projects, or results within the industry. It highlights BIO-key's unique biometric core platform supporting interoperable mixing and matching of different manufacturers' fingerprint scanners, which could be a competitive advantage.
• The company's PortalGuard and Identity-Bound Biometrics (IBB) are presented as addressing functional gaps not adequately covered by mainstream MFA solutions for enterprise workforce use cases, suggesting a differentiated offering.

Corporate Governance

Related Party Transactions

• Armistice Capital Master Fund Ltd. (the selling stockholder) has been involved in multiple warrant exercise agreements and a public offering of units with the company, indicating a significant ongoing financial relationship.

Stakeholder Impact

• **Shareholders**: Potential for significant dilution due to the registration of 6,183,336 shares for resale and future equity issuances. The 'going concern' warning poses a substantial risk to investment value. However, the company's ability to raise capital through warrant exercises provides some liquidity and operational funding.
• **Employees**: The company's strategic growth plans and pursuit of acquisitions could lead to expansion and new opportunities, but the 'going concern' risk introduces uncertainty regarding job security and long-term stability.
• **Customers**: Continued investment in product offerings and expansion into new markets (government, higher education, healthcare) suggests an ongoing commitment to serving and growing the customer base with enhanced IAM solutions.
• **Creditors**: The use of warrant exercise proceeds for working capital and repayment of outstanding secured notes is positive for creditors, reducing debt burden. However, the 'going concern' warning highlights underlying financial fragility.

Next Steps

• The company will amend the registration statement as necessary to delay its effective date until a further amendment specifically states effectiveness or until the SEC determines an effective date.
• The company will use commercially reasonable efforts to have the resale registration statement declared effective by the SEC within 90 calendar days following the October 27, 2025 Warrant Exercise Agreement.
• The company plans to continue increased marketing efforts into the IAM market.
• The company will continue dedicated pursuit of large-scale identification projects across the globe.
• The company aims to continue growing its channel alliance program.
• The company plans to pursue strategic acquisitions of select businesses and assets in the IAM space.

Key Dates

Recommendation

The explicit 'going concern' warning from the independent auditor is a critical red flag, indicating substantial doubt about the company's ability to continue operations. This fundamental financial instability, coupled with a stated 'history of losses and limited revenue,' outweighs the positive aspects of recent capital raises and growth strategies. The significant potential dilution from the registered resale, representing approximately 36% of outstanding shares post-exercise, also creates downward pressure on the stock price. While the company is raising capital, the underlying financial health appears precarious, making the stock a high-risk investment with a strong potential for further decline.

Keywords

Identity Access Management, IAM, Biometrics, MFA, Multi-Factor Authentication, SaaS, Software as a Service, Cybersecurity, Digital Identity, Authentication, SEC Filing, S-1, Warrants, Resale, BIO-key International